There are three main types of bone marrow transplant: autologous, which uses your own stem cells; allogeneic, which uses stem cells from a donor; and syngeneic, which uses cells from an identical twin. The right type depends on the disease being treated, whether a matched donor is available, and the patient’s overall health.
Transplants are used for a range of hematologic cancers and some inherited blood disorders. Below I walk through how each type works, where the stem cells come from, and what patients can expect.
What Is a Bone Marrow Transplant?
A bone marrow transplant (BMT) replaces damaged or diseased marrow with healthy hematopoietic stem cells, the cells that give rise to red cells, white cells, and platelets. The bone marrow is the soft tissue inside bones where these blood cells are made.
Today, the stem cells are more often collected from the bloodstream than from the marrow itself, which is why the terms bone marrow transplant and stem cell transplant are used almost interchangeably. You can read more about bone marrow transplant vs stem cell transplant and where the terms differ.
Not to be confused with the types of bone marrow in the body (red and yellow marrow), transplant types are defined by whose stem cells are used.
Autologous Transplant: Using Your Own Cells
In an autologous transplant, the patient’s own stem cells are collected and frozen. The patient then receives high-dose chemotherapy, sometimes with radiation, to destroy the disease. The stored cells are thawed and infused to rebuild the marrow.
The main purpose is to allow higher doses of chemotherapy than the marrow could otherwise survive. It is widely used for multiple myeloma and some relapsed lymphomas.
- Advantages: no donor needed, no risk of graft-versus-host disease, and generally a faster, safer recovery.
- Limitations: no graft-versus-tumor effect, and a small risk that the collected cells contain some disease.
Allogeneic Transplant: Cells From a Donor
In an allogeneic transplant, stem cells come from another person. Donors are matched using human leukocyte antigen (HLA) typing, which compares immune markers on the surface of cells.
Types of allogeneic donor
- Matched sibling donor: a brother or sister with the same HLA type. Each full sibling has about a one-in-four chance of being a match.
- Matched unrelated donor: a volunteer found through a donor registry.
- Haploidentical donor: a half-matched family member, such as a parent, child, or sibling.
- Umbilical cord blood: stem cells stored from a newborn’s cord, which can tolerate less exact matching.
Why allogeneic transplants are used
The donor’s immune cells can recognize and attack remaining cancer cells, known as the graft-versus-leukemia effect. This makes allogeneic transplant a key option for high-risk leukemia and lymphoma, as well as for aplastic anemia and inherited conditions such as severe sickle cell disease and thalassemia, where the goal is to replace faulty marrow entirely.
The trade-off is graft-versus-host disease (GVHD), where donor immune cells attack the patient’s tissues, most often the skin, gut, and liver.
Syngeneic Transplant: Cells From an Identical Twin
A syngeneic transplant uses stem cells from an identical twin. Because the genetic makeup is the same, the risk of rejection and GVHD is very low.
This is uncommon simply because few patients have an identical twin. It also offers little graft-versus-leukemia effect, so it behaves more like an autologous transplant in that respect.
Comparing the Different Types of Bone Marrow Transplants
| Feature | Autologous | Allogeneic | Syngeneic |
|---|---|---|---|
| Source of cells | Patient’s own | Related or unrelated donor, or cord blood | Identical twin |
| Donor matching needed | No | Yes, HLA typing | Naturally matched |
| Risk of GVHD | None | Yes | Very low |
| Graft-versus-cancer effect | No | Yes | Minimal |
| Common uses | Myeloma, some lymphomas | Leukemia, aplastic anemia, inherited blood disorders | Similar to autologous or allogeneic, depending on disease |
Transplants are also described by the intensity of the preparation. Myeloablative conditioning uses high-dose treatment to wipe out the marrow, while reduced-intensity conditioning uses lower doses and relies more on the donor’s immune effect. Reduced-intensity approaches have made allogeneic transplant possible for older or less fit patients.
What Happens Before and After a Transplant
Evaluation
Before transplant, patients have a full blood count, a bone marrow biopsy, heart, lung, kidney, and liver tests, and HLA typing if a donor is needed. The team also considers disease status, since outcomes such as the leukemia survival rate depend heavily on how well the disease is controlled going in.
Engraftment and recovery
After the infusion there is a period when blood counts are very low. Engraftment, when the new cells begin producing blood, usually takes about two to four weeks. Until then, patients are at high risk of infection and bleeding and often need transfusions.
Low platelets during this phase can cause bruising and bleeding, and many patients also notice profound tiredness; the link between low platelet count and fatigue is something we discuss with every transplant family. The team tracks PLT levels daily and transfuses when counts fall below safe thresholds. Our guide to managing platelet levels explains these numbers in more detail.
Supportive medicines include antibiotics, antivirals, antifungals, and, after allogeneic transplant, immunosuppressants to prevent GVHD.
Key Takeaways
- The three main types of bone marrow transplant are autologous, allogeneic, and syngeneic.
- Autologous transplants avoid GVHD but lack a graft-versus-cancer effect.
- Allogeneic transplants need a matched donor and carry GVHD risk, but can cure some leukemias and inherited disorders.
- Recovery involves a period of very low blood counts until engraftment.
Frequently Asked Questions
Which type of bone marrow transplant is safest?
Autologous transplants generally have fewer serious complications because there is no risk of GVHD or rejection. However, safety must be balanced against effectiveness, and for some diseases only an allogeneic transplant offers a chance of cure. Your transplant team will weigh both.
Does the donor have to be a family member?
No. Siblings are checked first, but many patients receive cells from unrelated registry volunteers, half-matched relatives, or cord blood. Half-matched family transplants have widened access for patients without a full match.
Is donating stem cells painful?
Most donations are now collected from the blood after a few days of growth-factor injections, which can cause bone aches. A marrow harvest from the hip bone is done under anesthesia and may leave soreness for a few days.
How long does recovery take?
Blood counts usually recover within weeks, but full immune recovery can take months, and longer after an allogeneic transplant. Close follow-up continues for at least the first year.
